News: Indonesia
21 July 2026
Strengthening the Government’s Preventive Health Efforts, Sustainable Health Program Reaches More Than 16,500 People
JAKARTA – More than 16,500 people across Indonesia have participated in the Cek Kesehatan Segitiga, a free health screening program organized by Dexa Medica through Dharma Dexa since 2024. Beyond providing blood pressure, blood glucose, and cholesterol screenings, the program, now conducted at 22 locations, also integrates health education, medical…
14 July 2026
Supporting the National Health Program, Cek Segitiga Serves More Than 15,000 People
Surabaya – Through Dharma Dexa, Dexa Medica continues to implement Cek Segitiga, a free community health screening program that supports the Indonesian government’s efforts to strengthen the early detection of non-communicable diseases (NCDs). Since its launch in 2024, the program has reached more than 15,000 people through blood pressure, blood…
9 June 2026
From Preventive Action to Meaningful Impact: Dexa Group Receives CSR Award 2026
Dexa Group's commitment to expanding healthcare access has once again been recognized. The company was honored with The Best Corporate Social Responsibility Award 2026 for Strengthening Social Solidarity and Healthcare Access Through Preventive Actions at the Indonesia Corporate Social and Environmental Responsibility Awards 2026, organized by Warta Ekonomi. The award…
28 May 2026
Early Detection in Cirebon: Six in Ten Participants Found to Be at High Risk
Cirebon — The government’s Free Health Screening program has only reached 21 percent of its target in Cirebon throughout 2025. In support of the Ministry of Health’s priority initiative, PT Dexa Medica through Dharma Dexa, brought the Cek Segitiga program to the city for the first time. Held at Stadion…
26 May 2026
Perubahan Kemasan Folamil Genio
Folamil Genio saat ini mengalami perubahan kemasan. Klik untuk info lebih lanjut.
20 May 2026
China Has TCM, India Has Ayurveda: Indonesia Advances OMAI Phytopharmaceuticals onto the Global Stage
Prof. Raymond Tjandrawinata's interview with CNBC Indonesia aired on 12 May 2026. The global herbal medicine market is projected to reach USD 600 billion by 2030. With the world’s second-largest biodiversity, Indonesia is stepping forward through science, research, and innovation. JAKARTA — The world has long recognized Traditional Chinese Medicine…
8 May 2026
Halal Pharmaceutical Products Strengthen Indonesia’s National Healthcare Ecosystem
Tangerang — Strengthening halal pharmaceutical products has become a shared priority among regulators, industry players, and healthcare providers in Indonesia. Ensuring the halal status of medicines is increasingly seen as essential to delivering safe, high-quality healthcare while providing peace of mind for the public. Indonesia’s Vice Minister of Health, Prof.…
29 April 2026
Ahead of the 2026 Deadline: Halal by Design, Dexa’s Commitment from the Earliest Stages of Research
Jakarta - In less than six months, Indonesia’s pharmaceutical industry landscape is set to change significantly. Starting October 17, 2026, all natural medicines, quasi-drugs, and health supplements distributed across the country must be halal-certified. For Indonesia’s 246 million Muslims—representing 87.08% of the national population, according to the Directorate General of…
20 April 2026
Thousands of People in Solo Join Free Health Check Program
Solo – More than 1,000 people in Solo took part in the Cek Segitiga, free health check program initiated by Dharma Dexa PT Dexa Medica at Manahan Stadium on Sunday, April 19, 2026. The strong turnout reflects growing public awareness of the importance of early detection through blood pressure, blood…
14 April 2026
High Public Enthusiasm in Bogor, Free Health Screening Draws Strong Interest
Bogor - A free health screening program received an enthusiastic response from residents of Bogor and surrounding areas. Results from the screening, which involved hundreds of participants, revealed that 7 out of 10 people—or 73.8%—are at risk of chronic diseases such as hypertension, diabetes, and high cholesterol. These findings highlight…
